Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CBLB | Q13191 | 2/20 | 0.34 |
| ▸ | TRPV3 | Q8NET8 | 5/20 | 0.32 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.32 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.32 |
| ▸ | CD274 | Q9NZQ7 | 4/20 | 0.32 |
| ▸ | PDCD1 | Q15116 | 3/20 | 0.32 |
| ▸ | VSIR | Q9H7M9 | 3/20 | 0.32 |
| ▸ | PDCD1LG2 | Q9BQ51 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30152863 | 1.00 | CBLB (0.34) | CBLBTRPV3S1PR1S1PR3CD274 | |
| SCHEMBL24820761 | 0.93 | VSIR (0.35) | CBLBTRPV3S1PR1S1PR3CD274 | |
| SCHEMBL24818917 | 0.93 | VSIR (0.35) | CBLBTRPV3S1PR1S1PR3CD274 | |
| SCHEMBL24818891 | 0.93 | VSIR (0.35) | CBLBTRPV3S1PR1S1PR3CD274 | |
| SCHEMBL24818680 | 0.93 | VSIR (0.35) | CBLBTRPV3S1PR1S1PR3CD274 | |
| SCHEMBL24819897 | 0.93 | CD274 (0.36) | CBLBTRPV3S1PR1S1PR3CD274 | |
| SCHEMBL24818854 | 0.93 | CD274 (0.36) | CBLBTRPV3S1PR1S1PR3CD274 | |
| SCHEMBL30152725 | 0.93 | CD274 (0.36) | CBLBTRPV3S1PR1S1PR3CD274 | |
| SCHEMBL24819898 | 0.93 | CD274 (0.36) | CBLBTRPV3S1PR1S1PR3CD274 | |
| SCHEMBL30153129 | 0.93 | CD274 (0.36) | CBLBTRPV3S1PR1S1PR3CD274 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022272248-A1 | CBL-B MODULATORS AND USES THEREOF | NIMBUS CLIO, INC. (US) | 2022-12-29 | — | — | WO | disclosed |